BDR Pharmaceutical on Tuesday said it has launched its generic version of Apalutamide, used in the treatment of prostate cancer, in India.
BDR Pharmaceutical on Tuesday said it has launched its generic version of Apalutamide, used in the treatment of prostate cancer, in India.